期刊文献+

脂质体包裹RNA和裸RNA在肿瘤RNA疫苗中作用的比较 被引量:3

Comparison of RNA/liposome complexes with naked RNA
下载PDF
导出
摘要 目的:比较有脂质体包裹的肿瘤RNA与无脂质体包裹的裸RNA转染未成熟树突状细胞(DC)后DC的成熟情况及其诱导的CTL对靶细胞的杀伤作用,以确定裸RNA能否有效转染DC。方法:从肺癌细胞系CALU-6中提取总RNA。采集肺癌患者PBMC富集血分离单个核细胞培养DC,第5天时将DC分成3组,A组用阳离子脂质体DMRIE-C与RNA共同转染DC,B组只用RNA转染DC,C组为DC对照组,继续培养5d后测定转染后3组DC的表面标志。转染后的A、B两组DC与自体淋巴细胞混合,诱导特异性CTL,LDH法测定诱导出的CTL的特异性杀伤活性。结果:与未进行转染的DC相比,A、B两组肿瘤细胞RNA转染DC后,CD1a、CD83及CD86、HLA-ABC都出现大幅度上调表达,说明两种方法转染RNA都可诱导DC的成熟。上述DC与自体淋巴细胞混合培养均可诱导出CTL,LDH释放实验显示,在效靶比40:1、20:1及10:1时两组DC诱导的CTL对同种靶细胞的杀伤活性比较无统计学差异,提示脂质体包裹RNA和裸RNA转染DC均可诱导特异性抗肿瘤免疫反应。结论:不需脂质体包裹的裸RNA与用脂质体包裹的RNA转染未成熟DC都能实现肿瘤细胞RNA信息进入DC,并一过性表达相应抗原,诱导DC成熟。二者都具有在体外诱导出自体CTL的特异性杀伤靶细胞的能力。 Objective: To compare the function of naked RNA and RNA/liposome complexes transfecting DC in inducing DCs maturity and priming CTL response. Methods: Total RNA was isolated from the lung cancer cell line CALU-6 and DCs were generated from PBMCs of lung cancer patients. Immature DCs were divided into 3 groups: DCs transfected with RNA/liposome complexes (Group A), DCs transfected with naked RNA (Group B) and DCs control (Group C). The phenotypes of 3 groups of DCs were characterized after 5 days culture. In group A or B, DCs were mixed with lymphocytes to induce CTLs. And the cytotoxicity was measured using LDH method. Results: Comparing with untranstected DCs, both A and B group of DCs expressed high levels of CD1a, CD83, CD86, ther naked RNA or RNA/liposome complexes can and HLA-ABC, which suggested that transfection of eiinduce maturation of DCs. CTLs were induced from the lymphocytes cocultured with DCs of each group. The result of LDH assay suggested there was no difference of cytotoxicity of CTLs between naked RNA and RNA/liposome complexes transfected DCs. Conclusion: Naked RNA is transfected into DCs to express tumor antigens and induce DCs maturation. Comparing with RNA/liposome complexes, naked RNA pulsed DCs can directly prime CTL response in vitro.
出处 《天津医科大学学报》 2008年第2期215-218,共4页 Journal of Tianjin Medical University
关键词 树突状细胞 脂质体 RNA疫苗 肺癌 Dendritic ceils Liposome RNA vaccine Lung cancer
  • 相关文献

参考文献8

  • 1Lu D, Benjamin R, Kim M, et al. Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors [J]. Cancer Gene Ther, 1994, 1(4):245
  • 2徐琪 邵莹 张乃宁etal.肿瘤患者自体树突状细胞的建立[J].中国肿瘤生物治疗杂志,1999,6(3):212-212.
  • 3Nair SK, Boczkowski D, Morse M, et al. Induction of primary carcinoembryonic antigen(CEA)-specific cytotoxiv T lymphocytes in vitro using human dendritic cells transfected with RNA[J]. Nat Biotechnol, 1998,16(4):364
  • 4Mitchell DA, Nair SK. RNA-transfected dendfiticcells in cancer immunotherapy[J]. J Clin Invest, 2000, 106(9): 1065
  • 5Boczkowski D, Nair ST, Nam JH, et al. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplifided from tumor cells [J]. Cancer Res, 2000, 60(4):1028
  • 6Tarte K, Klein B. Dendritic cell-based vaccines: a promising approach for cancer immunotherapy[J]. Leukemia, 1999, 13(5):653
  • 7Kuppner MC, Gastpar R, Gelwer S, et al. The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors [J]. Eur J Immunol, 2001,31(5):1602
  • 8Heiser A, Maurice MA, Yancey DR, et al. Human dendritic cells transfeeted with renal tumor RNA stimulate polyelonal T-cell responses against antigens expressed by primary and metastatic tumors [J]. Cancer Res, 2001 ,61(8):3388

共引文献3

同被引文献14

  • 1孙华文,汤聪,唐启彬,邹声泉,裘法祖.转存活素基因树突状细胞抗消化道肿瘤的免疫效应[J].中华外科杂志,2005,43(5):313-316. 被引量:4
  • 2Jian Qiu,Guo-Wei Li,Yan-Fang Sui,Hong-Ping Song,Shao-Yan Si,Wei Ge.Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo[J].World Journal of Gastroenterology,2006,12(3):473-478. 被引量:20
  • 3康玉,徐丛剑(审校).肿瘤细胞/树突状细胞融合疫苗的临床应用[J].国际免疫学杂志,2006,29(4):225-229. 被引量:4
  • 4高军,龚育平,赵平,杨晓平,戚中田.丙型肝炎病毒多表位抗原基因的构建与免疫原性研究[J].中国科学(C辑),2006,36(4):346-354. 被引量:9
  • 5Andersen MH, Pedersen LO, Becker JC, et al. Identification of a ey- totoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients [ J ]. Cancer Research, 2001, 61 (3) : 869 -872.
  • 6Piesche M, Hildebrandt Y, Zettl F, et al. Identification of a promis- cuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein surviving[ J ]. Human Immunology, 2007, 68 ( 7 ) : 572 - 576.
  • 7Lepisto AJ, Moser AJ, Zeh H, et al. A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors[J]. Cancer Ther, 2008, 6(B) : 955 -964.
  • 8Palmer DH, Midgley RS, Mirza N, et al. A phase Ⅱ study of adop- tive immunotherapy using dendritic cells pulse with lysate in patients with hepatocellnlar carcinoma[ J]. Hepatology, 2009, 49( 1 ) : 124 - 132.
  • 9Avigan DE, Vasir B, George D J, et al. Phase I/II study of vaccina- tion with eleetrofused allogeneic dendritic cells/autologous tumor-de- rived cells in patients with stage IV renal cell carcinoma[J]. J Immu- nother, 2007, 30(7): 749-761.
  • 10Pennati M, Folini M, Zaffaroni N. Targeting survivin in cancer thera- py : fulfilled promises and open questions[ J]. Carcinogenesis, 2007, 28(6) : 1133 - 1139.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部